37280 - NHS: Sustainable Development (Answered)

Norman Lamb
To ask the Secretary of State for Health, whether he plans to ask NHS England to publish the initial Sustainability and Transformation plans submitted on 15 April 2016 to permit scrutiny of those plans.

George Freeman

37123 - Science (Answered)

Nic Dakin
To ask the Secretary of State for Health, what his policy is on ensuring that all science-related government contracts and outsourced activities are awarded to organisations that demonstrate a commitment to high professional standards and invest in the professional development of their scientific workforce; and if he will make a statement.

George Freeman

36977 - Diseases: Medical Treatments (Answered)

Greg Mulholland
To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS England consultation on a proposed method to support investment decisions in specialised commissioning launched on 12 April 2016 does not disadvantage potential treatments for rare diseases.

George Freeman

36440 - Drugs: Wholesale Trade (Answered)

Charlotte Leslie
To ask the Secretary of State for Health, if he will take steps to increase competition in the pharmaceutical wholesale market.

George Freeman

The United Kingdom has an active and diverse licensed wholesale dealing market for medicinal products for human use which is regulated by the Medicines and Healthcare products Regulatory Agency. It is up to individual companies to submit such licence applications.

If there is concern with anti-competiveness, this should be referred to the Competition and Markets Authority.

36675 - Circumcision (Answered)

Philip Davies
To ask the Secretary of State for Health, what research his Department has conducted on the health benefits and risks of male circumcision.

George Freeman

The Department has not conducted or commissioned any specific research on the health effects of male circumcision.

36657 - Pregnancy: Epilepsy (Answered)

Cat Smith
To ask the Secretary of State for Health, what support he is providing for research into epilepsy medication for pregnant women.

George Freeman

The Department’s National Institute for Health Research is funding a £1.5 million evaluation of the effectiveness, cost effectiveness and acceptability of dose adjustment strategies in antiepileptic drug management in pregnancy. The report of the evaluation is expected to be published in February 2017.

36656 - Congenital Abnormalities: Sodium Valproate (Answered)

Cat Smith
To ask the Secretary of State for Health, if he will conduct an investigation into historical cases of birth defects caused by sodium valproate and the support now required by the families affected.

George Freeman

36655 - Pregnancy: Sodium Valproate (Answered)

Cat Smith
To ask the Secretary of State for Health, what steps he is taking to ensure that (a) clinical commissioning groups and (b) pharmacists are made aware of the Medicines and Healthcare products Regulatory Agency toolkit on the risks of valproate medicines in female patients.

George Freeman

36654 - Pregnancy: Sodium Valproate (Answered)

Cat Smith
To ask the Secretary of State for Health, what steps he is taking to monitor the effectiveness of the Medicines and Healthcare Products Regulatory Agency toolkit on the risks of valproate medicines in female patients in ensuring that female patients are better informed about the risks of taking valproate medicines during pregnancy.

George Freeman

36243 - Ehlers-Danlos Syndrome (Answered)

Hannah Bardell
To ask the Secretary of State for Health, what steps the Government is taking to raise awareness of Ehlers-Danlos Syndrome.

George Freeman

The Department has taken steps to increase public awareness of all rare diseases including conditions such as Ehlers-Danlos syndrome, through the implementation of the UK Strategy for Rare Diseases. The Strategy includes specific commitments to raise awareness of rare diseases.

Pages